Osteotec Signs Exclusive Distribution Agreement with icotec ag to advance Spine Tumour Therapy in Great Britain

Osteotec United Kingdom United States of America Switzerland

| 020 3011 5574
For more information, visit – www.osteotec.com

About icotec

icotec is the leading company for the treatment of spinal tumours and other indications with a new generation of high-tech implants. With its BlackArmor® Carbon/PEEK implants, icotec combines cutting-edge technologies and industry expertise to deliver innovative and reliable solutions for spine surgeons and their patients and is dedicated to advancing the field of spinal implantation.

With a track record of clinical success and a commitment to continuous innovation, icotec is poised to shape the future of spinal surgery. The comprehensive product portfolio has received FDA and CE clearance and is supported by numerous Key Opinion Leaders and spine surgery centres worldwide.

Media Contact:

John Clough
Vice President of Product Management and New Indications
[e-mail]
For more information, visit www.icotec-medical.com

Logo - https://mma.prnewswire.com/media/2151731/5310260/Osteotec_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/osteotec-signs-exclusive-distribution-agreement-with-icotec-ag-to-advance-spine-tumour-therapy-in-great-britain-302451009.html